Published ahead of print on November 1, 2007, doi:10.1164/rccm.200608-1190PP Am. J. Respir. Crit. Care Med., Volume 177, Number 4, February 2008, 369-375 A more recent version of this article appeared on February 15, 2008
Submitted on August 21, 2006 Cardiovascular Morbidity in Obstructive Sleep Apnea: Oxidative Stress, Inflammation, and Much MoreDavid Gozal1* and Leila Kheirandish-Gozal11 Division of Pediatric Sleep Medicine, Department of Pediatrics, Kosair Children's Hospital Research Institute, University of Louisville, Louisville, KY, USA * To whom correspondence should be addressed. E-mail: david.gozal{at}louisville.edu.
Sleep-disordered breathing and obstructive sleep apnea (OSA) are highly prevalent disorders throughout the lifespan, which may affect up to 2-10% of the population, and have now been firmly associated with an increased risk for cardiovascular and neurobehavioral complications. Nevertheless, the overall pathophysiological mechanisms mediating end-organ injury in OSA remain undefined, particularly due to the very frequent co-existence of other disease states such as obesity, that clearly complicate the potential cause-effect relationships. Two major and to some extent overlapping mechanisms have been proposed to explain the morbid consequences of OSA, namely increased generation and propagation of reactive oxygen species and initiation and amplification of inflammatory processes. The evidence supporting the validity of these concepts as well as that detracting from such mechanisms will be critically reviewed in the context of clinical and laboratory-based approaches. In addition, some of the contradictory issues raised by such evaluation of the literature will be interpreted in the context of putative modifications of the individual responses to OSA, as determined by genetic variants among susceptibility-related genes, and also by potential environmental modulators of the phenotypic expression of any particular end-organ morbidity associated with OSA. Key words: inflammation; oxidative stress; reactive oxygen species; intermittent hypoxia; sleep fragmentation
This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||